These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1101398)

  • 21. A moral-deontological examination of pharmacology.
    Honings B
    Dolentium Hominum; 1987; 4(2nd Yr. 1):46-54. PubMed ID: 11653198
    [No Abstract]   [Full Text] [Related]  

  • 22. Guidelines Relevant to the Procedure for Conduct of Clinical Trials.
    Ireland. National Drugs Advisory Board
    Int Dig Health Legis; 1987; 38(2):376-83. PubMed ID: 11649270
    [No Abstract]   [Full Text] [Related]  

  • 23. Is post-marketing drug follow-up research or advertising?
    Weiss GB; Winslade WJ
    IRB; 1987; 9(4):10-1. PubMed ID: 11649947
    [No Abstract]   [Full Text] [Related]  

  • 24. [The clinical evaluation of psychopharmaceuticals in internal and general medicine. Elements for continuing psychopharmacologic and research education of the primary care physician].
    Castillo Pérez P
    An Med Interna; 1988 Sep; 5(9):471-81. PubMed ID: 2856628
    [No Abstract]   [Full Text] [Related]  

  • 25. Perspectives of protocol reviewers.
    Moline ML; Aisen MW
    J Calif Alliance Ment Ill; 1994; 5(1):59-60. PubMed ID: 11653327
    [No Abstract]   [Full Text] [Related]  

  • 26. The ethics of phase I pediatric oncology trials.
    Ackerman TF
    IRB; 1995; 17(1):1-5. PubMed ID: 11653060
    [No Abstract]   [Full Text] [Related]  

  • 27. California laws on 'human experimentation' and 'experimental drugs'.
    Levine C
    IRB; 1979 Apr; 1(2):9-10. PubMed ID: 11661646
    [No Abstract]   [Full Text] [Related]  

  • 28. [Ethics and research: ethical considerations in clinical research].
    D'Haenen H
    Acta Psychiatr Belg; 1995; 95(6):332-6. PubMed ID: 8669304
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Playing roulette with experimental drugs.
    Budiansky S
    US News World Rep; 1987 Jul; 103(2):58-9. PubMed ID: 11658841
    [No Abstract]   [Full Text] [Related]  

  • 30. WHO views on responsibilities of research ethics boards and good clinical practice (GCP).
    Idänpään-Heikkilä J
    NCBHR Commun; 1993; 4(2):7-10. PubMed ID: 11652888
    [No Abstract]   [Full Text] [Related]  

  • 31. The FDA's enforcement of IRBs and patient informed consent.
    Kelsey FO
    Food Drug Cosmet Law J; 1989 Jan; 44(1):13-20. PubMed ID: 11651627
    [No Abstract]   [Full Text] [Related]  

  • 32. Control of pharmaceutical products and practice of pharmacy: Division VI. Protection of human subjects in clinical trials.
    Federal Republic of Germany
    Int Dig Health Legis; 1977; 28(3): 572-574 1977):. PubMed ID: 11660840
    [No Abstract]   [Full Text] [Related]  

  • 33. The war on cancer.
    Hawkins P
    Congr Rec (Dly Ed); 1981 Oct; 127(148):S11610-8. PubMed ID: 11658344
    [No Abstract]   [Full Text] [Related]  

  • 34. The burgeoning law of medical experimentation involving human subjects.
    Bryant LE
    John Marshall J Pract Proced; 1974; 8(1):19-51. PubMed ID: 11663465
    [No Abstract]   [Full Text] [Related]  

  • 35. FDA's biomedical research program.
    Kelsey FO
    J Parenter Drug Assoc; 1980; 34(2):134-8. PubMed ID: 6989974
    [No Abstract]   [Full Text] [Related]  

  • 36. Approving high risk, rejecting low risk: the case of two cases.
    Shannon TA; Ockene IS; Levine RJ
    IRB; 1985; 7(1):6-8. PubMed ID: 11649618
    [No Abstract]   [Full Text] [Related]  

  • 37. Placebo: pro and con.
    Lapierre YD; Weijer C
    NCEHR Commun; 1997-1998 Winter-Spring; 8(2):11-5. PubMed ID: 11660612
    [No Abstract]   [Full Text] [Related]  

  • 38. Biomedical technology--the ethical dilemmas.
    JSAC Grapevine; 1974 Dec; 6(5):1-8. PubMed ID: 11661093
    [No Abstract]   [Full Text] [Related]  

  • 39. Placebo-controlled trials and the logic of clinical purpose.
    Freedman B
    IRB; 1990; 12(6):1-6. PubMed ID: 11651265
    [No Abstract]   [Full Text] [Related]  

  • 40. Considering experimentation and elusive truth: informed consent made difficult.
    Brodeur D
    Issues (St Louis Mo); 1992; 7(2):1-8. PubMed ID: 11659444
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.